Security key
75943R102
Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)
CUSIP: 75943R102
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 4,389,099
- Total 13F shares
- 173,561,503
- Share change
- +2,872,674
- Total reported value
- $1,468,229,486
- Put/Call ratio
- 4.6%
- Price per share
- $8.46
- Number of holders
- 224
- Value change
- +$55,238,266
- Number of buys
- 109
- Number of sells
- 77
Report period
Q4 2025
Institutions
224
Top holders
10
RLAY full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Relay Therapeutics, Inc. SEC filings
Relay Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75943R102
Recent filing periods:
Top shareholders of RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
|
Company |
636%
|
27,904,963
|
$145,663,907 | — | 30 Sep 2025 | |
| Casdin Capital, LLC |
13D/G
13F
|
Company |
7.5%
|
13,003,574
|
$110,010,236 | $0 | 31 Dec 2025 | |
| Commodore Capital LP |
13D/G
13F
|
Company |
9.9%
|
17,000,000
|
$88,740,000 | +$19,053,000 | 30 Sep 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
337%
|
14,773,676
|
$77,118,589 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
6.1%
from 13D/G
|
13,759,382
|
$71,823,974 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
214%
|
9,395,744
|
$49,045,785 | — | 30 Sep 2025 | |
| Bellevue Group AG |
13F
|
Company |
190%
|
8,345,610
|
$43,564,084 | — | 30 Sep 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
184%
|
8,068,058
|
$42,115,263 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
115%
|
5,065,990
|
$26,444,468 | — | 30 Sep 2025 | |
| Nextech Invest, Ltd. |
13F
|
Company |
88%
|
3,846,409
|
$20,078,255 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
70%
|
3,054,586
|
$15,947,600 | — | 30 Sep 2025 | |
| Kynam Capital Management, LP |
13F
|
Company |
66%
|
2,887,014
|
$15,070,213 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
57%
|
2,482,950
|
$12,960,818 | — | 30 Sep 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
52%
|
2,282,680
|
$11,915,590 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
43%
|
1,868,871
|
$9,755,506 | — | 30 Sep 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
41%
|
1,810,351
|
$9,450,032 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
40%
|
1,764,096
|
$9,208,581 | — | 30 Sep 2025 | |
| Alphabet Inc. |
13F
|
Company |
36%
|
1,568,753
|
$8,188,891 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
30%
|
1,301,036
|
$6,791,407 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
27%
|
1,195,843
|
$6,242,302 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
27%
|
1,174,971
|
$6,133,349 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
27%
|
1,165,434
|
$6,083,565 | — | 30 Sep 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
26%
|
1,160,117
|
$6,055,811 | — | 30 Sep 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
26%
|
1,137,681
|
$5,940,000 | — | 30 Sep 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
26%
|
1,124,300
|
$5,868,846 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
25%
|
1,111,331
|
$5,801,148 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
25%
|
1,095,635
|
$5,719,215 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
23%
|
1,023,110
|
$5,340,634 | — | 30 Sep 2025 | |
| Woodline Partners LP |
13F
|
Company |
23%
|
1,018,115
|
$5,314,560 | — | 30 Sep 2025 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
23%
|
1,000,000
|
$5,220,000 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
17%
|
744,044
|
$3,883,910 | — | 30 Sep 2025 | |
| BESSEMER GROUP INC |
13F
|
Company |
13%
|
584,463
|
$3,051,000 | — | 30 Sep 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
12%
|
541,124
|
$2,824,667 | — | 30 Sep 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
11%
|
501,238
|
$2,614,000 | — | 30 Sep 2025 | |
| Eversept Partners, LP |
13F
|
Company |
11%
|
479,056
|
$2,500,672 | — | 30 Sep 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
11%
|
467,362
|
$2,439,630 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
11%
|
462,379
|
$2,413,619 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
11%
|
461,879
|
$2,411,009 | — | 30 Sep 2025 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
10%
|
460,000
|
$2,401,200 | — | 30 Sep 2025 | |
| CONGRESS ASSET MANAGEMENT CO |
13F
|
Company |
9.3%
|
408,842
|
$2,134,155 | — | 30 Sep 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
9.3%
|
408,840
|
$2,134,000 | — | 30 Sep 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
9%
|
393,704
|
$2,055,135 | — | 30 Sep 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
8.6%
|
379,363
|
$1,980,275 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
8.5%
|
371,578
|
$1,939,639 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
8.2%
|
361,190
|
$1,885,412 | — | 30 Sep 2025 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
7.7%
|
339,080
|
$1,769,998 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
6.6%
|
288,450
|
$1,505,709 | — | 30 Sep 2025 | |
| Brian Adams |
3/4/5
|
Chief Legal Officer |
—
mixed-class rows
|
646,472
mixed-class rows
|
$1,367,016 | -$73,378 | 28 Jul 2025 | |
| HighVista Strategies LLC |
13F
|
Company |
5.5%
|
240,459
|
$1,255,196 | — | 30 Sep 2025 | |
| Swiss National Bank |
13F
|
Company |
5.3%
|
232,700
|
$1,214,694 | — | 30 Sep 2025 |
Institutional Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY) as of Q4 2025
As of 31 Dec 2025,
Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY) was held by
224 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
173,561,503 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, Commodore Capital LP, Point72 Asset Management, L.P., BlackRock, Inc., Casdin Capital, LLC, VANGUARD GROUP INC, Bellevue Group AG, STATE STREET CORP, Nextech Invest, Ltd., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
224
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
195
Q4 2025 holders
224
Holder diff
29
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.